Multiple organ dysfunction syndrome in children with sepsis: role of genetic factors

Orfeas Liangos1, Bertrand L Jaber

  • 1Division of Nephrology, Caritas St. Elizabeth's Medical Center and Tufts University School of Medicine, 736 Cambridge Street, Boston, MA 02135, USA.

Seminars in Nephrology
|September 16, 2008
PubMed

Insights

Genetic markers influence childhood inflammatory disorders, including severe infections. Understanding these genetic links aids in predicting susceptibility, severity, and outcomes in pediatric patients.

Area of Science:

  • Pediatric infectious diseases
  • Genetic epidemiology
  • Inflammatory disorders

Background:

  • Acute inflammatory disorders in children, particularly systemic infections, pose significant health challenges.
  • Genetic factors are increasingly recognized as playing a role in disease susceptibility and severity.
  • Understanding these genetic influences is crucial for improving pediatric patient outcomes.

Purpose of the Study:

  • To review current knowledge on the impact of genetic markers on susceptibility, severity, and outcome of acute inflammatory disorders in children.
  • To highlight the role of genetic epidemiology in studying common pediatric disorders.
  • To discuss limitations and future research directions in this field.

Main Methods:

  • Comprehensive review of pertinent literature on genetic markers and pediatric inflammatory disorders.
  • Case study analysis of a child with Neisseria meningitides bacteremia, septic shock, and multiple organ dysfunction.
  • Integration of genetic epidemiology principles.

Main Results:

  • Genetic markers significantly impact susceptibility and severity of acute inflammatory conditions in children.
  • Case study illustrates the complex interplay between infection, genetic predisposition, and clinical outcomes.
  • Current literature provides a foundation for understanding genetic influences, but gaps remain.

Conclusions:

  • Genetic markers are critical determinants of susceptibility, severity, and outcome in pediatric inflammatory disorders.
  • Further research in genetic epidemiology is essential for advancing personalized medicine in pediatrics.
  • Future studies should focus on identifying specific genetic variants and their functional roles.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...